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 Dear Editor 
 
Takotsubo cardiomyopathy (TTC), otherwise known as stress-induced 
cardiomyopathy (broken heart syndrome) is characterized by rapidly reversible heart 
failure with transient left ventricular wall motion abnormality without the presence of 
significant coronary artery disease 1. According to a review, perioperative TTC 
occurs in 1/6700 surgical procedures 2. 
A 48-year-old post-menopausal lady was scheduled to have a rigid 
cystoscopy and removal of urethral stent along with retrograde pyelogram as an 
elective procedure. She had been diagnosed with breast cancer and had bilateral 
mastectomy in the past. The patient also had chronic stress issues and depression.  
She was on tamoxifen 20 mg/day for her breast cancer and desvenlafaxine 50 
mg/day for her depression. She had no known cardiac problems. Her blood results 
including electrolytes were unremarkable. 
For the procedure, under standard monitoring, the patient underwent a routine 
anesthetic management with a laryngeal mask airway using propofol for induction, 
oxygen, air and sevoflurane for maintenance and fentanyl for analgesia. The patient 
was in normal sinus rhythm and was hemodynamically stable throughout the 
procedure. A couple of minutes prior to the conclusion of the surgery, with 
sevoflurane at a minimum alveolar concentration (MAC) of 0.7, she abruptly went 
into an asystolic cardiac arrest while the stent was being removed. Cardiac 
compressions were started. As 4 ml of 1:10000 intravenous epinephrine and 0.6 mg 
of atropine were administered, sinus rhythm had returned with a heart rate of 46 per 
minute and a blood pressure of 90/56 mm Hg. Patient was intubated and radial 
arterial as well as central venous lines were placed. Phenylephrine 100 mcg was 
administered resulting in a blood pressure of 127/74 mm Hg. Intravenous 
epinephrine infusion was then started at 0.02 mcg/kg/min to prevent any further 
hemodynamic instability. On-table transthoracic echocardiogram revealed extensive 
akinesia of midventricular and apical segment with preservation of basal segments, 
moderate impairment of left ventricular systolic function with ejection fraction of 36% 
(Figure 1). Coronary angiogram performed immediately after the event, was normal. 
A tentative diagnosis of TTC was made and patient was ventilated and monitored in 
intensive care unit (ICU).  Chest X ray was unremarkable. An increase in troponin 
levels and a prolongation of QT interval was observed (>500 ms) throughout that day 
following the event. Peak value of troponin (2.0 ng/ml) occurred on first postoperative 
day and the increase in troponin persisted up to 48 hours. Contrast echocardiogram, 
performed the next day showed some perfusion signal in the apex suggestive of 
early stage of recovery.  The following day, the epinephrine infusion was weaned off 
and the patient was discharged from ICU. She was discharged after a week with oral 
bisoprolol and perindopril. Due to the suspicion of desvenlafaxine induced 
cardiomyopathy, it was tapered down gradually to avoid withdrawal and eventually 
ceased. A repeat echocardiogram three months later was found to be entirely normal 
(Figure 2). The patient had subsequently undergone general anesthesia for non-
cardiac procedures uneventfully. 
TTC predominantly affects women of postmenopausal age with emotional or 
physical stress. Possible mechanisms vary from coronary artery spasm, 
microvascular dysfunction, impaired fatty acid metabolism within the myocardium 
and myocardial stunning from a catecholamine surge 3-5. There are published case 
reports about the possibility of serotonin/noradrenaline reuptake inhibitor (SNRI) 
group of drugs such as venlafaxine, desvenlafaxine and duloxetine precipitating TTC 
due to the increased catecholamine levels on a background of stress, anxiety and 
depression6-8. None of the reported cases of TTC with venlafaxine seem to have 
occurred in the perioperative period9. Desvenlafaxine is an active metabolite of 
venlafaxine. QT prolongation with venlafaxine seems to be a concern, however there 
seems to be limited evidence on the cardiac adverse effects of desvenlafaxine 
compared to venlafaxine10.  
Iatrogenic catecholamine administration has also been described as one of 
the possible precipitants of TTC11, although in our case, we had administered low 
dose epinephrine after cardiac arrest occurred. Patients with anxiety and depression 
are said either develop high catecholamine responses with stress or have increased 
cardiac sensitivity to endogenous catecholamines12. Reduction of estrogen levels in 
postmenopausal women has also been implicated in the pathogenesis of TTC13. For 
the same reason, cardiotoxicity of selective estrogen receptor modulator (SERM) 
tamoxifen, has also been questioned in a previous report on TTC14.  
Out of the published perioperative TTC, 58% have occurred in the immediate 
postoperative period; only a few have presented as cardiac arrest in the 
intraoperative period. Most frequent presentation of perioperative TTC seem to be 
heart failure, arrhythmias or cardiac arrest2.  The management of TTC is mainly 
supportive care including inotropes, diuretics, vasodilators15. Long-term prognosis is 
generally good and normalization occurs within weeks. Recurrence of the syndrome 
is relatively rare (around 1.5% per year)2. 
Although TTC seems to be rare and unpredictable, caution should be 
exercised while managing the potentially vulnerable group of patients, post-
menopausal women by providing anxiolysis and ensuring optimum pain relief and 
adequate depth of anesthesia, thereby minimising perioperative stressors. In 
addition, cardiac side effects of antidepressants and anticancer drugs in general, 
need to be carefully considered while prescribing these medications.  
 
 
 
FIGURE LEGENDS 
 
 
Figure 1:  
Apical 2 chamber view (immediately after the arrest) showing apical ballooning of left 
ventricle. 
 
Figure 2:   
Apical 2 chamber view (3 months post arrest) showing normal contractility of the left 
ventricular apex. 
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